Vulcan Value Partners cited Elevance Health as a key contributor to its Q2 2026 returns, with the stock up 32.82% over the past year.
Elevance Health (ELV) closed at $375.98 per share on July 29, 2026, reflecting a market capitalization of $81.54 billion. The stock posted a one-month return of -10.03% but gained 32.82% over the past 52 weeks, according to Vulcan Value Partners’ Q2 2026 investor letter.
Vulcan Value Partners reported strong performance across its composites, with returns ranging from 9.0% to 13.3% in Q2 2026. The firm emphasized its focus on long-term value and undervalued holdings, naming Elevance Health as a notable contributor to its gains.
The firm’s Large Cap Composite (Net) returned 9.5%, while its Small Cap Composite (Net) led with a 13.3% gain. Elevance Health was highlighted alongside UnitedHealth Group as a material driver of performance.